About this trial
The goal of this clinical trial is to learn if the hips of people who undergo revision hip arthroscopy look different from the hips of people whose hip pain is resolved with the first hip arthroscopy and of people who choose the steroid injection for pain management.
Participants will complete one PET/MRI scan.
Eligibility criteria
Qualifiers
Age 18-45
History of unilateral hip arthroscopy
Does not have evidence of fracture, infection, or malignancy at 6 months post-hip arthroscopy
Does not have evidence of depression or other major mental health conditions before the index hip arthroscopy
Disqualifiers
No unilateral hip arthroscopy
Evidence of fracture, infection, or malignancy at 6 months post-hip arthroscopy
Evidence of depression or other major mental health conditions before the index hip arthroscopy
Has persistent pain that requires opioid use, or has a history of opioid abuse
Trial design
Treatments tested in this trial
- FDG PET/MRI
Treatment groups
Sponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
Arthroscopy Association of North America
Collaborator